<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02481128</url>
  </required_header>
  <id_info>
    <org_study_id>SenSzi (GBG80)</org_study_id>
    <nct_id>NCT02481128</nct_id>
  </id_info>
  <brief_title>Surgical Trial to Evaluate the Impact of a Lymphoscintigraphy Prior to Sentinel Node Biopsy in Early Breast Cancer</brief_title>
  <official_title>Randomized Controlled Multicenter Surgical Trial to Evaluate the Impact of a Lymphoscintigraphy Prior to Sentinel Node Biopsy in Early Breast Cancer; SenSzi (GBG80)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kliniken Essen-Mitte</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Breast Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kliniken Essen-Mitte</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sentinel node biopsy is a well established tool for axillary staging in early breast cancer.
      So far the impact of a preoperative lymph node scintigraphy is unclear. This study aims to
      clarify whether a preoperative lymphoscintigraphy is of additional benefit in a prospective
      randomized multicenter study design.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sentinel node biopsy is a well established tool for axillary staging in early breast cancer.
      So far the impact of a preoperative lymph node scintigraphy is unclear. Several studies
      indicate sentinel node biopsy to be a reliable method irrespective of prior lymph node
      scintigraphy, but data from prospective randomized trials are not available.

      Although a preoperative lymph node scintigraphy is not explicitly demanded in current S3
      guidelines in Germany its performance is a common practice.

      If a preoperative lymphoscintigraphy could be safely omitted, possible benefits are a
      facilitation of the preoperative workflow as well as cost reduction for health care systems.

      This study aims to clarify whether a preoperative lymphoscintigraphy is of additional benefit
      in a prospective randomized study design. In the two study arms sentinel node biopsy is
      performed either with or without knowledge of the preoperative lymphoscintigraphy findings.
      Primary end point is the average number of histologically detected sentinel lymph nodes per
      patient in both treatment arms.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">January 2017</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Average number of histologically detected sentinel lymph nodes per patient</measure>
    <time_frame>Histological report expected within an average of 2 weeks after sentinel lymph node biopsy</time_frame>
    <description>Number of resected sentinel lymph nodes is inversely correlated with false negative rate of sentinel lymph node biopsy. Average number of histologically detected sentinel lymph nodes per patient is assessed through pathologic report and serves as surrogate marker for false negative rate of sentinel node biopsy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of patients with proven metastasis in sentinel lymph nodes</measure>
    <time_frame>Histological report expected within an average of 2 weeks after sentinel lymph node biopsy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of completion axillary dissection with proven metastasis in sentinel lymph nodes</measure>
    <time_frame>histological report on subsequent completion axillary dissection within 6 months after initial sentinel lymph node biopsy</time_frame>
    <description>A completion axillary dissection can be performed in case of proven metastasis in sentinel lymph nodes. A completion axillary dissection ca be performed either right away during sentinel lymph node biopsy or after completion of neoadjuvant chemotherapy. Hence assessment will be performed within 6 months after initial sentinel lymph node biopsy in order to include all patients planned for neoadjuvant chemotherapy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Detection rates of sentinel nodes lymph nodes with preoperative lymphoscintigraphy vs. intraoperative gamma probe and histological detection rates of sentinel lymph nodes with vs. without preoperative access to lymphoscintigraphy</measure>
    <time_frame>Histological report expected within an average of 2 weeks after sentinel lymph node biopsy</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1198</enrollment>
  <condition>Early-Stage Breast Carcinoma</condition>
  <arm_group>
    <arm_group_label>A (access to lymphoscintigraphy)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Axillary sentinel lymph node biopsy with preoperative access to lymphoscintigraphy findings</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B (no access to lymphoscintigraphy)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Axillary sentinel lymph node biopsy without preoperative access to lymphoscintigraphy findings</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>without preoperative access to lymphoscintigraphy findings</intervention_name>
    <description>axillary sentinel lymph node biopsy without access to lymphoscintigraphy findings</description>
    <arm_group_label>B (no access to lymphoscintigraphy)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  invasive mamma carcinoma as verified by core cut biopsy

          -  extensive ductal carcinoma in situ as verified by core cut biopsy (at least 5 cm or at
             least 2,5 cm and G3 grading)

          -  clinical stage tumor T1-T3

          -  no signs of axillary lymph node metastasis on clinical examination including
             ultrasound examination

          -  no signs of distant metastatic disease

          -  male/ female patient in the age not less than 18 years

          -  Karnofsky performance status at least 70% or Eastern Cooperative Oncology Group (ECOG)
             score not higher than 1

          -  written patient informed consent

        Exclusion Criteria:

          -  suspect axillary lymph nodes on clinical/ultrasound examination

          -  positive fine-needle biopsy of axillary lymph nodes

          -  sentinel lymph node biopsy to be performed after neoadjuvant chemotherapy

          -  recurrence of a mamma carcinoma

          -  prior extensive surgery of breast or axilla

          -  inflammatory or extramammary breast cancer

          -  pregnancy

          -  contraindication to the radionuclide

          -  inability to understand the studies purpose

          -  inability to receive surgery

          -  no written patient informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sherko Kümmel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kliniken Essen-Mitte</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thorsten Kühn, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Klinikum Esslingen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Johannes Holtschmidt, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Kliniken Essen-Mitte</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kliniken Essen-Mitte</name>
      <address>
        <city>Essen</city>
        <state>Nordrhein-Westfalen</state>
        <zip>45136</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brustzentrum im Klinikum Ansbach</name>
      <address>
        <city>Ansbach</city>
        <zip>91522</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brustzentrum am Hochwaldkrankenhaus Bad Nauheim</name>
      <address>
        <city>Bad Nauheim</city>
        <zip>61231</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kreisklinik Ebersberg, Brustzentrum</name>
      <address>
        <city>Ebersberg</city>
        <zip>85560</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik für Frauenheilkunde &amp; Geburtshilfe, Klinikum Esslingen</name>
      <address>
        <city>Esslingen</city>
        <zip>73730</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Agaplesion Markus Krankenhaus Frankfurt, Brustzentrum</name>
      <address>
        <city>Frankfurt a. M.</city>
        <zip>60431</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Franziskus Hospital Harderberg, Brustzentrum Osnabrück</name>
      <address>
        <city>Georgsmarienhütte</city>
        <zip>49129</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asklepios Harzkliniken Goslar, Brustzentrum</name>
      <address>
        <city>Goslar</city>
        <zip>38642</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Gütersloh, Klinik für Frauenheilkunde und Geburtshilfe</name>
      <address>
        <city>Gütersloh</city>
        <zip>33332</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sankt Elisabeth Krankenhaus Gütersloh, Frauenklinik</name>
      <address>
        <city>Gütersloh</city>
        <zip>33332</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kreiskrankenhaus Bergstrasse, Brustzentrum</name>
      <address>
        <city>Heppenheim</city>
        <zip>64646</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Schleswig-Holstein, Brustzentrum Kiel</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsfrauenklinik Magdeburg, Brustzentrum</name>
      <address>
        <city>Magdeburg</city>
        <zip>39108</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus Bethesda, Brustzentrum Niederrhein</name>
      <address>
        <city>Mönchengladbach</city>
        <zip>41061</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsfrauenklinik am Klinikum Südstadt Rostock</name>
      <address>
        <city>Rostock</city>
        <zip>18059</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DRK Krankenhaus Saarlouis, Brustzentrum</name>
      <address>
        <city>Saarlouis</city>
        <zip>66740</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leopoldina Krankenhaus Schweinfurt, Brustzentrum</name>
      <address>
        <city>Schweinfurt</city>
        <zip>97422</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum St. Elisabeth Straubing, Brustzentrum</name>
      <address>
        <city>Straubing</city>
        <zip>94304</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Katharinen Hospital Unna, Brustzentrum</name>
      <address>
        <city>Unna</city>
        <zip>59423</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kliniken Nordoberpfalz, Frauenklinik</name>
      <address>
        <city>Weiden</city>
        <zip>92637</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marien-Hospital Wesel, Brustzentrum</name>
      <address>
        <city>Wesel</city>
        <zip>46483</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brustzentrum Bern, Engerriedspital/Lindenhofspital</name>
      <address>
        <city>Bern</city>
        <zip>3012</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 5, 2015</study_first_submitted>
  <study_first_submitted_qc>June 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2015</study_first_posted>
  <last_update_submitted>January 31, 2017</last_update_submitted>
  <last_update_submitted_qc>January 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>lymphoscintigraphy</keyword>
  <keyword>sentinel lymph node biopsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

